To include your compound in the COVID-19 Resource Center, submit it here.

Sofosbuvir/velpatasvir/GS-9857: Phase II data

Top-line data from the open-label, U.S. Phase II TRILOGY-3 trial in 49 DAA-experienced patients with chronic HCV genotype 1 infection with or without

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE